NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

In this sense I understand you. But unconsciously lots of investors are just doing the same and you can include 99% of the total negative comments in this category, leaving that 1% from the naked short wolfpack, or those paid to post, or those claim to have no shares, long or short, but post 24/7 for years.

None of these matter in the end. In the grand thing of matter, DCVax-L will be approved as a treatment for ndGMB patient, and perhaps for rGBM patients as well, suggested by the first secondary endpoint, of course if data shows strong evidence it helps rGBM patients as well.

because we know the primary endpoint will be readily met ss, and it's most likely some of the secondary endpoints will also be met ss.

For a treatment, which is easy to administerd, almost no side effects, a so so treatment effect will easily warrant an approval, let alone its effects being better than anything on the market, based on the blinded blended data we all have known.